An Open-label, Multi-center, Expanded Treatment Protocol of Pasireotide LAR in Patients With Acromegaly



Status:Approved for marketing
Conditions:Skin Cancer, Endocrine
Therapuetic Areas:Endocrinology, Oncology
Healthy:No
Age Range:18 - Any
Updated:4/21/2016

Use our guide to learn which trials are right for you!

An ACromegaly, Open-label, Multi-CEnter, Safety Monitoring Program for Treating Patients With SOM230 (Pasireotide) LAR Who Have Need to Receive Medical Therapy (ACCESS)

The present study is planned as an expanded treatment protocol to provide acromegalic
patients for whom medical therapy is appropriate access to pasireotide LAR while regulatory
approval for pasireotide is sought.


Inclusion Criteria:

- Patients with confirmed diagnosis of active acromegaly with elevated IGF-1 (>ULN) and
random GH (>1 μg/L) within 30 days of screening.

- Patients who are not controlled by pituitary surgery or who are not eligible for or
refuse surgery.

- For patients on medical treatment for acromegaly the following washout periods must
be completed before screening assessments are performed:

- Dopamine agonists (bromocriptine, cabergoline): 4 weeks

- GH-receptor antagonists (pegvisomant): 8 weeks

- Somatostatin analogues: no washout period required

- Karnofsky performance status ≥ 60.

Exclusion Criteria:

- Concomitant treatment with somatostatin analogues unless concomitant treatment was
discontinued 28 days before first pasireotide LAR injection is administrated.

- Concomitant treatment with growth hormone receptor (GHR)-antagonists or dopamine
agonists unless concomitant treatment was discontinued and the washout period was
completed before the screening assessments are performed.

- Patients with compression of the optic chiasm causing any visual field defect for
whom surgical intervention is indicated.

- Patients who require a surgical intervention for relief of any sign or symptom
associated with tumor compression.

- Patients who have undergone major surgery/surgical therapy for any cause within 4
weeks of screening.

- Patients who have received radiotherapy of the pituitary within 4 weeks prior to
screening or have not recovered from side effects of radiotherapy.

- Patients who have a history of hypothyroidism and who are not adequately treated with
stable doses of thyroid hormone replacement therapy.

- Patients with active malignant disease within the last five years (with the exception
of basal cell carcinoma or carcinoma in situ of the cervix).

- Diabetic patients whose blood glucose is poorly controlled.

Other protocol-defined inclusion/exclusion criteria may apply.
We found this trial at
37
sites
?
mi
from
Phoenix, AZ
Click here to add this to my saved trials
1 Brookings Drive
St. Louis, Missouri 63110
 (314) 935-5000
Washington University Washington University creates an environment to encourage and support an ethos of wide-ranging...
?
mi
from
St. Louis, MO
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
?
mi
from
Atlanta, GA
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
?
mi
from
Baltimore, MD
Click here to add this to my saved trials
1876 5th Avenue South
Birmingham, Alabama 35294
?
mi
from
Birmingham, AL
Click here to add this to my saved trials
Boston, Massachusetts 02111
?
mi
from
Boston, MA
Click here to add this to my saved trials
Chesapeake, Virginia 23321
?
mi
from
Chesapeake, VA
Click here to add this to my saved trials
?
mi
from
Chicago, IL
Click here to add this to my saved trials
Chula Vista, California 91911
?
mi
from
Chula Vista, CA
Click here to add this to my saved trials
?
mi
from
Columbus, GA
Click here to add this to my saved trials
?
mi
from
Columbus, OH
Click here to add this to my saved trials
East Setauket, New York 11733
?
mi
from
East Setauket, NY
Click here to add this to my saved trials
?
mi
from
Hollywood, FL
Click here to add this to my saved trials
?
mi
from
Houston, TX
Click here to add this to my saved trials
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Los Angeles, CA
Click here to add this to my saved trials
?
mi
from
Maitland, FL
Click here to add this to my saved trials
Nashville, Tennessee 37203
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
Nashville, TN
Click here to add this to my saved trials
?
mi
from
New Brunswick, NJ
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
?
mi
from
New York, NY
Click here to add this to my saved trials
Ocoee, Florida 34761
?
mi
from
Ocoee, FL
Click here to add this to my saved trials
?
mi
from
Peoria, AZ
Click here to add this to my saved trials
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
?
mi
from
Portland, OR
Click here to add this to my saved trials
Rochester, Minnesota 55905
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
Santa Monica, CA
Click here to add this to my saved trials
?
mi
from
Seattle, WA
Click here to add this to my saved trials
Smithtown, New York 11787
?
mi
from
Smithtown, NY
Click here to add this to my saved trials
?
mi
from
Toledo, OH
Click here to add this to my saved trials
?
mi
from
Torrance, CA
Click here to add this to my saved trials
?
mi
from
Washington,
Click here to add this to my saved trials